BioNTech is forming an alliance of 13 companies to implement a plan to produce 2 billion doses of the COVID-19 vaccine this year. In addition to BioNTech partner Pfizer, it will also include its competitors: Switzerland's Novartis, Germany's Merck, and France's Sanofi. Joint production should help cope with vaccine shortages in the EU and other countries.